Tag Archives: cancer drug fund

UK’s Controversial Cancer Fund Boosted — But What’s the Long-Term Plan?

By Leela Barham. The English Cancer Drugs Fund (CDF), set up to provide funding for those products that the National Institute for Health and Care Excellence (NICE) has not recommended for use or where their guidance isn’t yet available, remains controversial. Initially penciled for closure in 2014, it is now planned to run to 2016. […]
Posted in Europe, Guest Blog, Op-Ed, pricing | Also tagged , , , , , | Leave a comment

Big Pharma Welcomes Extension to England's Cancer Drug Fund, Critics Unconvinced

The Cancer Drugs Fund: Extension to 2016 By Leela Barham The Cancer Drugs Fund (CDF) in England covers the cost of cancer treatments either when the National Institute for Health and Care Excellence (NICE) has said ‘no’, or hasn’t yet come to a view.  It started with £50 million and is now £200million a year. […]
Posted in Europe, Global, Guest Blog, Op-Ed | Also tagged , , , , , | Leave a comment

England's Cancer Drug Fund: An Acid Test for Value Based Pricing

By Leela Barham. England’s Cancer Drugs Fund (CDF) could be in its final financial year, after running in full since April 2011.  The fund covers the cost of cancer treatments either when NICE has said ‘no’, or hasn’t yet come to a view.  Companies can’t circumvent NICE though; if a company was invited to submit […]
Posted in Europe, Global, Guest Blog, Op-Ed, pricing | Also tagged , , , , | Leave a comment
  • Categories

  • Meta